Voleon Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$338K Sell
675
-72
-10% -$34.6K 0.01% 657
2026
Q1
$367K Buy
747
+174
+30% +$94.4K 0.01% 629
2025
Q4
$332K Sell
573
-3,316
-85% -$1.88M 0.01% 652
2025
Q3
$1.89M Sell
3,889
-2,929
-43% -$1.36M 0.05% 323
2025
Q2
$2.76M Sell
6,818
-1,066
-14% -$446K 0.15% 147
2025
Q1
$3.92M Buy
+7,884
New +$4.27M 0.31% 80
2019
Q4
Sell
-22,000
Closed -$6.41M 234
2019
Q3
$6.41M Buy
+22,000
New +$6.3M 0.49% 47
2019
Q1
Sell
-70,000
Closed -$15.7M 59
2018
Q4
$15.7M Buy
+70,000
New +$16.4M 1.49% 25

Other funds holding TMO

Voleon Capital Management's TMO Position: Q2 2026 in Review

Voleon Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 9.6% in Q2 2026, selling an estimated $34.6K and leaving 675 shares worth $338K. The position accounts for 0.01% of the portfolio, ranked #657.

Voleon Capital Management first reported a position in TMO in Q4 2018 and has held it in 8 quarters since. The position peaked at $15.7M in Q4 2018. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Voleon Capital Management held 675 shares of Thermo Fisher Scientific worth $338K as of Q2 2026.
  • Voleon Capital Management sold 72 Thermo Fisher Scientific shares in Q2 2026, an estimated $34.6K.
  • Thermo Fisher Scientific made up 0.01% of Voleon Capital Management's portfolio in Q2 2026, its #657 holding.
  • Voleon Capital Management first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 8 quarters since.
  • Voleon Capital Management's Thermo Fisher Scientific position peaked at $15.7M in Q4 2018.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.